Literature DB >> 11212874

Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats.

Y Shuto1, T Shibasaki, K Wada, I Parhar, J Kamegai, H Sugihara, S Oikawa, I Wakabayashi.   

Abstract

Growth hormone (GH) secretagogues (GHSs), which stimulate GH secretion, are synthetic compounds that act through the GHS receptor (GHS-R) which has been recently cloned. We raised an antiserum in a rabbit against a synthetic peptide corresponding to amino acid residues 248-260 of the third intracellular loop of the rat GHS-R. A competitive immunoassay showed that the antiserum had a specific affinity for the target peptide. To confirm the specificity of the antiserum, the GHS-R cDNA was stably expressed in COS-7 cells. In Western blot analysis, the band was detected at 44 kDa in the extracts from COS-7 cells expressing GHS-R (COS-7/tf3-2) but not in those from wild-type COS-7 cells. Furthermore, while COS-7/tf3-2 cells were strongly immunostained for GHS-R, no GHS-R-like immunoreactivity was observed in wild-type COS-7 cells. Immunoreactive bands were also observed at approximately 46 kDa in the extracts from rat hypothalamus, pituitary and stomach by Western blot analysis. These studies are the first to show the existence of GHS-R protein in the stomach. The antiserum for the GHS-R is sensitive and specific, and it would be useful for clarifying the roles of GHS/ghrelin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212874     DOI: 10.1016/s0024-3205(00)01001-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  24 in total

1.  Ghrelin attenuates brain injury after traumatic brain injury and uncontrolled hemorrhagic shock in rats.

Authors:  Lei Qi; Xiaoxuan Cui; Weifeng Dong; Rafael Barrera; Jeffrey Nicastro; Gene F Coppa; Ping Wang; Rongqian Wu
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 2.  Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis.

Authors:  Cletus Cheyuo; Asha Jacob; Ping Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-08       Impact factor: 4.310

3.  Expression of ghrelin receptor mRNA in the rat and the mouse brain.

Authors:  Jeffrey M Zigman; Juli E Jones; Charlotte E Lee; Clifford B Saper; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

Review 4.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

5.  Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock.

Authors:  Rongqian Wu; Mian Zhou; Weifeng Dong; Youxin Ji; Michael Miksa; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

6.  Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats.

Authors:  Kazunori Fujino; Akio Inui; Akihiro Asakawa; Naoki Kihara; Masaki Fujimura; Mineko Fujimiya
Journal:  J Physiol       Date:  2003-07-01       Impact factor: 5.182

7.  Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis.

Authors:  Kavin G Shah; Rongqian Wu; Asha Jacob; Steven A Blau; Youxin Ji; Weifeng Dong; Corrado P Marini; Thanjavur S Ravikumar; Gene F Coppa; Ping Wang
Journal:  Mol Med       Date:  2009-09-18       Impact factor: 6.354

Review 8.  Brain foods: the effects of nutrients on brain function.

Authors:  Fernando Gómez-Pinilla
Journal:  Nat Rev Neurosci       Date:  2008-07       Impact factor: 34.870

Review 9.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

10.  Ghrelin in central neurons.

Authors:  F Ferrini; C Salio; L Lossi; A Merighi
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.